Plooster Matthew R 4
4 · ZEVRA THERAPEUTICS, INC. · Filed Mar 13, 2023
Insider Transaction Report
Form 4
Plooster Matthew R
Director
Transactions
- Purchase
Common Stock
2023-03-09$4.20/sh+11,000$46,148→ 18,500 total
Holdings
- 1,532
Common Stock
- 69(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]Held jointly with spouse.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.1166 to $4.26, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.